Vertaling van "administration of blood components " (Nederlands → Frans) :

haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.
haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.

serious adverse reactions in blood donors and recipients of blood components ●● Proposing measures for the evaluation of
serious adverse reactions in blood donors and recipients of blood components ●● Proposing measures for the evaluation of

serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about
serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about

cell and tissue banks ●● Pricing of blood components, tissues and
cell and tissue banks ●● Pricing of blood components, tissues and

Guide to the preparation, use andquality assurance of blood components.
Guide to the preparation, use and quality assurance of blood components.

Safety of Blood Components Meeting, PEI, 21/03/03.
of Blood Components Meeting, PEI, 21/03/03.

Nucleic acid sequence based amplification Nucleic Acid Amplification Testing Non-heart beating donors National Institute for Biological Standards and Control Optische densiteit Occupational Safety and Health Administration Perazijnzuur Phosphate buffered saline Polymerase chain reaction Perazijnzuur ethanol sterilisatie Positive predictive value Positief predictieve waarde Polyvinyl-pyrrolidon Povidone-iodine Quaternaire ammoniumverbindingen Radio-immunoprecipitatie test Ribonucleic acid Ribonuclease H Respiratoir syncytiaal virus Reverse transcriptase Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Median tissue culture infective dose Transcription-mediated amplification Tumor necrosis factor United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Verenigde Staten Werkgroep infectiepreventie West Nile virus World Health Organization
Morbidity and mortalility weekly report Nucleic acid sequence based amplification Nucleic Acid Amplification Testing National Institute for Biological Standards and Control Occupational Safety and Health Administration Phosphate buffered saline ou tampon phosphate Polymerase chain reaction Stérilisation acide peracétique-éthanol Positive predictive value Polyvinyl-pyrrolidon Povidone-iodine Dérivés de l’ammonium quaternaire Ribonuclease H Reverse transcriptase ou transcriptase inverse Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Syndrome d’immunodéficience acquise Median tissue culture infective dose Test d’immunofluorescence indirecte Transcription-mediated amplification Tumor necrosis factor Test de radio-immunoprécipitation United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Valeur prédictive positive Virus respiratoire syncytial Etats-Unis Werkgroep infectiepreventie ou groupe de travail sur la prévention des infections West Nile virus World Health Organization

EPINet TM : Exposure Prevention Information Network (standardized methods for recording and tracking percutaneous injuries and blood and body fluid contacts) FDA: Food and Drug Administration EFPSU: European Federation of Public Service Unions FOD (SPF): Federale OverheidsDienst FBZ: Fonds voor de BeroepZiekten FTC: Emtricitabine GERES: Groupe d ‘Etudes sur le Risque d’Exposition des Soignants (Frankrijk) HAART: Highly active anti retroviral therapy HBV: Hepatitis B virus HBIg: Hepatitis B-immunoglobulin HBe Ag: Hepatitis B-virus core-antigeen HBs Asn: Antistoffen tegen het oppervlakteantigeen van het hepatitis B-virus HCV: Hepatitis C virus HGR: Hoge Gezondheidsraad HGV: Hepatitis G virus HIV: Human immunodeficiency virus HOSPEEM: European Hospital and Healthcare Employers’ Association IDPB: Interne Dienst voor Preventie en Bescherming op het werk IU : International unit (viro titration) NRTI : Nucleoside reverse transcriptase inhibitor NNRTI : Non-nucleoside reverse transcriptase inhibitor OK: Operatiekwartier PBW: Preventie en Bescherming op het Werk PCR: Polymerase chain reaction PI : Protease inhibitor PEP: Post exposure prophylaxis PSO: Prik- en spatongeval (= accidentele contacten met bloed en andere lichaamsvochten) QD: Quaque die (elke dag) RNA: Ribonucleic acid RH: Rusthuis RVT: Rust- en verzorgingstehuizen SIV : Simian immunodeficiency virus (Immunodeficiëntievirus bij apen) TDF : Tenofovir UN xxxx: four-digit numbers that identify hazardous substances assigned by United Nations VAZG: Vlaams Agentschap Zorg en Gezondheid VTE: Voltijds equivalent WIV: Wetenschappelijk Instituut voor Volksgezondheid WZC: Woon- en zorgcentra 3TC: Lamivudine
CDC: Centers for Diseases Control and Prevention (USA) CJD: Creutzfeldt–Jakob disease Cp: Comprimé CSS: Conseil Supérieur de la Santé EACS: European Aids Clinical Society EPI: Equipements de protection individuelle. EPINet TM : Exposure Prevention Information Network (standardized methods for recording and tracking percutaneous injuries and blood and body fluid contacts) FDA: Food and Drug Administration EFPSU: European Federation of Public Service Unions ETP: Equivalent temps-plein FMP: Fonds des Maladies Professionnelles FTC: Emtricitabine GERES: Groupe d ‘Etudes sur le Risque d’Exposition des Soignants (France) HAART: Highly active anti retroviral therapy HOSPEEM: European Hospital and Healthcare Employers’ Association IgHB: Immunoglobulines anti-hépatite B IM: Intra-musculaire IMP: Institut médico-pédagogique INTI: Inhibiteur nucléosidique de la transcriptase inverse INNT: Inhibiteur non nucléosidique de la transcriptase inverse ISP (WIV): Institut Scientifique de Santé Publique LCR: Liquide céphalo-rachidien MR-MRS: Maison de repos – Maison de repos et de soins PCR: Polymerase chain reaction PI: Protease inhibitor (inhibiteur de protéase) PPE: Prophylaxie post-exposition QD: Quaque die (chaque jour) QO: Quartier opératoire SEPPT: Service Externe de Prévention et de Protection au travail SIDA: Syndrome de l'immunodéficience acquise SIPPT: Service Interne de Prévention et de Protection au travail SPF: Service Public Fédéral TDF: Tenofovir UI: Unité internationale UN xxxx : Four-digit numbers that identify hazardous substances assigned by United Nations VIH: Virus de l’immunodéficience humaine VHB: Virus de l’hépatite B VHC: Virus de l’hépatite C VHG: Virus de l’hépatite G VSI: Virus simien de l’immunodéficience 3TC: Lamivudine